Tumor infiltrating lymphocytes

Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma
Pooja Ghatalia, Jennifer Gordetsky, Fengshen Kuo, Essel Dulaimi, Kathy Q. Cai, Karthik Devarajan, Sejong Bae, Gurudatta Naik, Timothy A. Chan, Robert Uzzo, A. Ari Hakimi, Guru Sonpavde, Elizabeth Plimack

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 139; DOI: 10.1186/s40425-019-0621-1
STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models
Weiqing Jing, Donna McAllister, Emily P. Vonderhaar, Katie Palen, Matthew J. Riese, Jill Gershan, Bryon D. Johnson, Michael B. Dwinell

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 115; DOI: 10.1186/s40425-019-0573-5
Immune profiling of pre- and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trial
Xiaotong Li, Sarah Warren, Vasiliki Pelekanou, Vikram Wali, Alessandra Cesano, Mingdong Liu, Patrick Danaher, Nathane Elliott, Zeina A. Nahleh, Daniel F. Hayes, Gabriel N. Hortobagyi, William E. Barlow, Christos Hatzis, Lajos Pusztai

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 88; DOI: 10.1186/s40425-019-0563-7
Interaction of host immunity with HER2-targeted treatment and tumor heterogeneity in HER2-positive breast cancer
Gaia Griguolo, Tomás Pascual, Maria Vittoria Dieci, Valentina Guarneri, Aleix Prat

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 90; DOI: 10.1186/s40425-019-0548-6
Merger of dynamic two-photon and phosphorescence lifetime microscopy reveals dependence of lymphocyte motility on oxygen in solid and hematological tumors
Mateusz Rytelewski, Karine Haryutyunan, Felix Nwajei, Meenakshi Shanmugasundaram, Patrick Wspanialy, M. Anna Zal, Chao-Hsien Chen, Mirna El Khatib, Shane Plunkett, Sergei A. Vinogradov, Marina Konopleva, Tomasz Zal

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 78; DOI: 10.1186/s40425-019-0543-y
HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1
Chu-Yu Jing, Yi-Peng Fu, Yong Yi, Mei-Xia Zhang, Su-Su Zheng, Jin-Long Huang, Wei Gan, Xin Xu, Jia-Jia Lin, Juan Zhang, Shuang-Jian Qiu, Bo-Heng Zhang

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 77; DOI: 10.1186/s40425-019-0554-8
Gene expression markers of Tumor Infiltrating Leukocytes
Patrick Danaher, Sarah Warren, Lucas Dennis, Leonard D’Amico, Andrew White, Mary L. Disis, Melissa A. Geller, Kunle Odunsi, Joseph Beechem, Steven P. Fling

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 18; DOI: 10.1186/s40425-017-0215-8
Clinical significance of tumor-infiltrating lymphocytes in breast cancer
Sasha E. Stanton, Mary L. Disis

Journal for ImmunoTherapy of Cancer Dec 2016, 4 (1) 59; DOI: 10.1186/s40425-016-0165-6
Target discovery for T cell therapy: next steps to advance Immunotherapies
Adrian Bot, Joanna E Brewer, Zelig Eshhar, Stanley R Frankel, Emma Hickman, Achim A Jungbluth, Richard Morgan, Yoav Peretz, Laszlo Radvanyi, Carlos A Ramos, Paul F Robbins, Kai W Wucherpfennig

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (1) 31; DOI: 10.1186/s40425-015-0061-5
Detailed characterization of tumor infiltrating lymphocytes in two distinct human solid malignancies show phenotypic similarities
Magdalena Kovacsovics-Bankowski, Lana Chisholm, Jonna Vercellini, Christopher G Tucker, Ryan Montler, Daniel Haley, Philippa Newell, Jun Ma, Paul Tseng, Ronald Wolf, John T Vetto, Chet Hammill, Paul Hansen, Andrew D Weinberg

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 38; DOI: 10.1186/s40425-014-0038-9

Log in using your username and password

Main menu

Log in using your username and password

You are here

Tumor infiltrating lymphocytes